Shares of Humanigen Inc. HGEN, -80.10% plunged 67.9% in premarket trading on Wednesday, the day after the company said a National Institutes of Health clinical trial testing lenzilumab and Gilead Scie...
Shares of Humanigen Inc. HGEN, -80.10% plunged 67.9% in premarket trading on Wednesday, the day after the company said a National Institutes of Health clinical trial testing lenzilumab and Gilead Scie...